Advertisement

Topics

FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA® ...

09:00 EDT 19 Jun 2017 | BioMedReports - Blog

"Multiple myeloma patients with fractures and other bone complications have a very poor prognosis. Bisphosphonates are the only approved class of agents for the prevention

Read more...

Original Article: FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA® ...

NEXT ARTICLE

More From BioPortfolio on "FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA® ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...